James Huang, Director at CASI Pharmaceuticals, Inc. (CASI), bought 84,054 shares at $3.75 ($315K) on 2022-08-26, disclosed to the SEC on 2022-08-26.
Open-market purchase of $315k CASI by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.75 | 5,000 | $19K | 5.9% |
| 2 | $3.75 | 39,527 | $148K | 47.0% |
| 3 | $3.75 | 39,527 | $148K | 47.0% |
| Total | $3.75 avg | 84,054 | $315K | 100% |
| Filing → |
| ATRA | SELL | 2026-01-14 | $489K | — | Filing → |
| ATRA | BUY | 2025-07-21 | $373K | — | Filing → |
| CASI | BUY | 2022-09-08 | $304K | — | Filing → |